CTRI/2018/05/014223进行中（未招募）未知
A5288 Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE) - A5288
IH DAIDS0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •HIV-1 infection
- •Any previous combination of ARV treatment at any time with at least one regimen that contained one NNRTI and two NRTIs which was replaced with a PI-based regimen because of virologic, immunologic, or clinical treatment failure, or because of toxicity
排除标准
- •Pregnancy or breast-feeding.
- •Known allergy/sensitivity or any hypersensitivity to components of study drugs or their formulation.
- •Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
- •Serious illness requiring systemic treatment and/or hospitalization until candidate either completes therapy or is clinically stable on therapy, in the opinion of the site investigator, for at least 7 days prior to study entry.
- •Concurrent illness or condition that would compromise the ability to take study medication, follow the protocol, or that would make participation not in the best interest of the participant, per the site investigator.
- •Requirement for taking any of the prohibited medications with the selected ARV study regimen, or within 14 days prior to study entry.
- •Active tuberculosis (TB) or rifampin exposure less than 2 weeks prior to study entry.
研究者
相似试验
未知
不适用
MANAGEMENT USING THE LASTEST THECNOLOGIES IN RESOURCE-LIMITED SETTINGS TO OPTIMIZE COMBINATION THERAPY AFTER VIRAL FAILURE (MULTI-OCTAVE)PER-118-11INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS,32
进行中（未招募）
4 期
Management Using Latest Technologies to Optimize Combination Therapy After Viral FailureCTRI/2017/09/009938ational Institute Of Allergy and Infectious DiseasesNIAIDNIH100
已完成
不适用
Advanced techniques have been developed to overcome difficult cannulation cases in endoscopic retrograde cholangiopancreatography (ERCP ). Pancreatic duct guidewire placement method (PGW) is performed in difficult cannulation cases; it is possible that it places patients at risk of post-ERCP pancreatitis (PEP). The mechanism of PEP is still unclear, but pancreatic duct pressure and injury of pancreatic duct are known causes of PEP. Therefore, we hypothesized a relationship between pancreatic duct diameter and PEP and predicted that PGW would increase the risk of PEP in patients with non-dilated pancreatic ducts. This study aimed to investigate whether PGW increased the risk of PEP in patients with pancreatic duct diameter <3 mm.pancreatic and bile duct diseaseJPRN-UMIN000026416osaka city university332
招募中
不适用
ImmUniverse Work Package 5 AD: Better control and treatment of Atopic Dermatitis disease by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesatopic dermatitispsoriasis10014982NL-OMON49924Radboud Universitair Medisch Centrum80
已完成
不适用
Towards a smart and intuitive controlled MyLeg prosthesis: acquisition of intramuscular electromyography for motion intention detection. A pilot study.NL-OMON49529Revalidatiecentrum Het Roessingh15